RRMS Patients Explain Difficulty Managing The Disease During The Covid-19 Pandemic

Lemtrada Stroke Lawsuit News

Lemtrada's life-threatening side effects are compounded by the deadly Coronavirus that confuses an already compromised immune system

Thursday, May 21, 2020 - Health experts in the field of relapse-remitting multiple sclerosis (RRMS) are concerned that the Covid-19 health crisis has made seeking treatment more difficult for fear of contracting the virus and having an already weakened immune system that could make the disease's symptoms much worse. Multiple Sclerosis News Today asked the question "How Has Covid-19 Affected Your MS Life?" and their readership offered their insight into a side of the pandemic most feared by RRMS patients. Lemtrada attorneys are offering a no obligation, free consultation to people suffering side effects from taking Lemtrada for multiple sclerosis such as Stroke and Arterial Dissection.

One patient answered that Covid-19 convinced him to cancel his follow up visit to his doctor to have his blood drawn to test for any signs of the frequent adverse symptoms from his drug therapy that included taking Lemtrada (alemtuzumab), after first consulting and getting the approval of his neurologist. Another patient reported that his legs had stiffened and that he was having more trouble walking yet he canceled his semi-annual doctor's visit due to Coronavirus health concerns. Others have had mixed reactions such as a few patients that were in the middle of their disease-modifying therapies when the pandemic struck. On the one hand, patients in the middle of treatment fear continuing because to continue taking the immunosuppressant make contracting the disease more likely, but on the other hand, having a suppressed immune system may work in their favor to mitigate the "cytokine storm" of the body's overreaction to the virus, an overreaction that attacks the lungs and blood chemistry. A patient in the middle of therapy was quoted as having written on social media "Currently getting my Ocrevus infusion. It was an extremely difficult decision for me to make. I felt like I had to choose between my MS getting worse or an increased chance of catching & dying from CoVid due to immunosuppression." And to add insult to injury, the simple act of traveling to or being present in a doctor's office or hospital getting their disease-modifying therapy drug could increase one's chances of contracting the Coronavirus. People are continuing to ride on mass transportation in enclosed vehicles, buses, and subways.

All of the issues presented above act to complicate a situation that is already difficult to manage. Many RRMS sufferers have taken Lemtrada to help them cope with the disease but have been left worse off than when they began. Lemtrada patients have suffered heart attacks and strokes and a litany of precautions must be made before, during, and after receiving Lemtrada therapy for fear of suffering instant death. The drug's potential to cause physical harm including death should not be underestimated. Last month I wrote that the European Pharmaceutical Review described Lemtrada's life-threatening side effects as " "Unpredictable and potentially fatal immune-mediated reactions can occur within months and up to at least four years after treatment with the drug. Reactions included autoimmune hepatitis, haemophagocytic lymphohistiocytosis, and acquired hemophilia A. The review identified serious cases of Epstein-Barr virus reactivation reported after treatment, including hepatitis. Some patients developed more than one autoimmune disorder following treatment."

If you are suffering from the adverse side effects of Lemtrada or other disease-modifying therapy, you may wish to seek the guidance of a top attorney to see if you qualify to file a claim for reimbursement of your medical expenses and other damages you may have suffered.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.